With funds from NIH, Barbara Nikolajczyk is tracking the trajectory of type 2 diabetes. She's following metabolically healthy people as they naturally progress to diabetes, looking for potential drug targets along the way.
UK computational chemist Chad Risko starts at the atomic level to design new materials for lithium ion batteries and electrical grid storage.
With the Markey Cancer Center, Ellingson uses molecular docking as a filtering process to efficiently and safely screen potential drugs before real-world experiments begin.
In a new $2.9 million NIDA-funded project, William Stoops will compare the health effects of reduced cocaine use with abstinence.
This project will collect, transcribe, edit and publish the complete writings of Dickinson, who wrote more for the American cause than any other founding father.
Kip Guy, Pharmacy Dean, is discovering and developing new drugs for neglected diseases.
The similarities between a plant and human protein may be the key to curing Lafora disease.
Kalea Benner's research emphasizes the importance of asking the tough questions to find solutions.
Thomas Guskey conducts research on the way teachers grade and how they report that information to parents.
Aaron Garvey's research focuses on how brands can have placebo effects on consumers.